10x Genomics (TXG) Net Income (QoQ) (2018 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Net Income (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.12% |
| Mar 31, 2026 | 17.12% |
| Dec 31, 2025 | 40.84% |
| Sep 30, 2025 | -179.54% |
| Jun 30, 2025 | 200.52% |
| Mar 31, 2025 | 29.92% |
| Dec 31, 2024 | -37.13% |
| Sep 30, 2024 | 5.66% |
| Jun 30, 2024 | 36.78% |
| Mar 31, 2024 | -22.46% |
| Dec 31, 2023 | 47.36% |
| Sep 30, 2023 | -48.98% |
| Jun 30, 2023 | -22.99% |
| Mar 31, 2023 | -194.78% |
| Dec 31, 2022 | 58.93% |
| Sep 30, 2022 | 34.97% |
| Jun 30, 2022 | -51.98% |
| Mar 31, 2022 | -129.89% |
| Dec 31, 2021 | -7.44% |
| Sep 30, 2021 | -55.37% |